@article{015cec0de55143cea69e53afbfedcd89,
title = "Essential Characteristics of Pharmacogenomics Study Publications",
abstract = "Pharmacogenomics (PGx) can be seen as a model for biomedical studies: it includes all disease areas of interest and spans in vitro studies to clinical trials, while focusing on the relationships between genes and drugs and the resulting phenotypes. This review will examine different characteristics of PGx study publications and provide examples of excellence in framing PGx questions and reporting their resulting data in a way that maximizes the knowledge that can be built on them.",
author = "Thorn, {Caroline F.} and Michelle Whirl-Carrillo and Houda Hachad and Johnson, {Julie A.} and McDonagh, {Ellen M.} and Ratain, {Mark J.} and Relling, {Mary V.} and Scott, {Stuart A.} and Altman, {Russ B.} and Klein, {Teri E.}",
note = "Funding Information: C.F.T., M.W.C., and T.E.K. were supported by National Institutes of Health/National Institute of General Medical Sciences GM61374, GM 115264, and HG010135. M.V.R. received funding from National Institutes of Health CA21765, GM115279, and GM 115264. Funding Information: C.F.T., M.W.C., and T.E.K. were supported by National Institutes of Health/National Institute of General Medical Sciences GM61374, GM 115264, and HG010135. M.V.R. received funding from National Institutes of Health CA21765, GM115279, and GM 115264. The authors thank Maria Alvarellos, Julia Barbarino, and Melissa Landrum for critical reading of the manuscript. Publisher Copyright: {\textcopyright} 2018 American Society for Clinical Pharmacology and Therapeutics",
year = "2019",
month = jan,
doi = "10.1002/cpt.1279",
language = "English",
volume = "105",
pages = "86--91",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Wiley-Blackwell",
number = "1",
}